Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2012

Kinsella MD, Nassar A, Siddiqui MT, Cohen C. Estrogen receptor (ER), progesterone receptor (PR), and HER2 expression pre- and post- neoadjuvant chemotherapy in primary breast carcinoma: a single institutional experience. Int J Clin Exp Pathol. 2012;5(6):530-6.

Boiocchi L, Orazi A, Ghanima W, Arabadjief M, Bussel JB, Geyer JT. Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities. Mod Pathol. 2012;25(1):65-74.

Magro CM, Yang S-, Zippin JH, Zembowicz A. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins. Arch Pathol Lab Med. 2012;136(12):1558-64.

Rickman DS, T Soong D, Moss B, Mosquera JM, Dlabal J, Terry S, et al. Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci U S A. 2012;109(23):9083-8.

Poché RA, Sharma R, Garcia MD, Wada AM, Nolte MJ, Udan RS, et al. Transcription factor FoxO1 is essential for enamel biomineralization. PLoS One. 2012;7(1):e30357.

Liu L, Yin Y, Li Y, Prevedel L, Lacy EH, Ma L, et al. Essential role of the CUL4B ubiquitin ligase in extra-embryonic tissue development during mouse embryogenesis. Cell Res. 2012;22(8):1258-69.

Quinn AS, Wu X-, Rand JH, Taatjes DJ. Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy. Micron. 2012;43(8):851-62.

Esgueva R, Park K, Kim R, Kitabayashi N, Barbieri CE, Dorsey PJ, et al. Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium. Diagn Mol Pathol. 2012;21(2):61-8.

Wahezi DM, Ilowite NT, Rajpathak S, Rand JH. Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases. J Rheumatol. 2012;39(2):382-8.

Matignon M, Muthukumar T, Seshan SV, Suthanthiran M, Hartono C. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Transplantation. 2012;94(6):603-11.